An open-source deep learning network AVA-Net for arterial-venous area segmentation in optical coherence tomography angiography.


Journal

Communications medicine
ISSN: 2730-664X
Titre abrégé: Commun Med (Lond)
Pays: England
ID NLM: 9918250414506676

Informations de publication

Date de publication:
17 Apr 2023
Historique:
received: 22 11 2022
accepted: 06 04 2023
medline: 18 4 2023
entrez: 17 4 2023
pubmed: 18 4 2023
Statut: epublish

Résumé

Differential artery-vein (AV) analysis in optical coherence tomography angiography (OCTA) holds promise for the early detection of eye diseases. However, currently available methods for AV analysis are limited for binary processing of retinal vasculature in OCTA, without quantitative information of vascular perfusion intensity. This study is to develop and validate a method for quantitative AV analysis of vascular perfusion intensity. A deep learning network AVA-Net has been developed for automated AV area (AVA) segmentation in OCTA. Seven new OCTA features, including arterial area (AA), venous area (VA), AVA ratio (AVAR), total perfusion intensity density (T-PID), arterial PID (A-PID), venous PID (V-PID), and arterial-venous PID ratio (AV-PIDR), were extracted and tested for early detection of diabetic retinopathy (DR). Each of these seven features was evaluated for quantitative evaluation of OCTA images from healthy controls, diabetic patients without DR (NoDR), and mild DR. It was observed that the area features, i.e., AA, VA and AVAR, can reveal significant differences between the control and mild DR. Vascular perfusion parameters, including T-PID and A-PID, can differentiate mild DR from control group. AV-PIDR can disclose significant differences among all three groups, i.e., control, NoDR, and mild DR. According to Bonferroni correction, the combination of A-PID and AV-PIDR can reveal significant differences in all three groups. AVA-Net, which is available on GitHub for open access, enables quantitative AV analysis of AV area and vascular perfusion intensity. Comparative analysis revealed AV-PIDR as the most sensitive feature for OCTA detection of early DR. Ensemble AV feature analysis, e.g., the combination of A-PID and AV-PIDR, can further improve the performance for early DR assessment. Some people with diabetes develop diabetic retinopathy, in which the blood flow through the eye changes, resulting in damage to the back of the eye, called the retina. Changes in blood flow can be measured by imaging the eye using a method called optical coherence tomography angiography (OCTA). The authors developed a computer program named AVA-Net that determines changes in blood flow through the eye from OCTA images. The program was tested on images from people with healthy eyes, people with diabetes but no eye disease, and people with mild diabetic retinopathy. Their program found differences between these groups and so could be used to improve diagnosis of people with diabetic retinopathy.

Sections du résumé

BACKGROUND BACKGROUND
Differential artery-vein (AV) analysis in optical coherence tomography angiography (OCTA) holds promise for the early detection of eye diseases. However, currently available methods for AV analysis are limited for binary processing of retinal vasculature in OCTA, without quantitative information of vascular perfusion intensity. This study is to develop and validate a method for quantitative AV analysis of vascular perfusion intensity.
METHOD METHODS
A deep learning network AVA-Net has been developed for automated AV area (AVA) segmentation in OCTA. Seven new OCTA features, including arterial area (AA), venous area (VA), AVA ratio (AVAR), total perfusion intensity density (T-PID), arterial PID (A-PID), venous PID (V-PID), and arterial-venous PID ratio (AV-PIDR), were extracted and tested for early detection of diabetic retinopathy (DR). Each of these seven features was evaluated for quantitative evaluation of OCTA images from healthy controls, diabetic patients without DR (NoDR), and mild DR.
RESULTS RESULTS
It was observed that the area features, i.e., AA, VA and AVAR, can reveal significant differences between the control and mild DR. Vascular perfusion parameters, including T-PID and A-PID, can differentiate mild DR from control group. AV-PIDR can disclose significant differences among all three groups, i.e., control, NoDR, and mild DR. According to Bonferroni correction, the combination of A-PID and AV-PIDR can reveal significant differences in all three groups.
CONCLUSIONS CONCLUSIONS
AVA-Net, which is available on GitHub for open access, enables quantitative AV analysis of AV area and vascular perfusion intensity. Comparative analysis revealed AV-PIDR as the most sensitive feature for OCTA detection of early DR. Ensemble AV feature analysis, e.g., the combination of A-PID and AV-PIDR, can further improve the performance for early DR assessment.
Some people with diabetes develop diabetic retinopathy, in which the blood flow through the eye changes, resulting in damage to the back of the eye, called the retina. Changes in blood flow can be measured by imaging the eye using a method called optical coherence tomography angiography (OCTA). The authors developed a computer program named AVA-Net that determines changes in blood flow through the eye from OCTA images. The program was tested on images from people with healthy eyes, people with diabetes but no eye disease, and people with mild diabetic retinopathy. Their program found differences between these groups and so could be used to improve diagnosis of people with diabetic retinopathy.

Autres résumés

Type: plain-language-summary (eng)
Some people with diabetes develop diabetic retinopathy, in which the blood flow through the eye changes, resulting in damage to the back of the eye, called the retina. Changes in blood flow can be measured by imaging the eye using a method called optical coherence tomography angiography (OCTA). The authors developed a computer program named AVA-Net that determines changes in blood flow through the eye from OCTA images. The program was tested on images from people with healthy eyes, people with diabetes but no eye disease, and people with mild diabetic retinopathy. Their program found differences between these groups and so could be used to improve diagnosis of people with diabetic retinopathy.

Identifiants

pubmed: 37069396
doi: 10.1038/s43856-023-00287-9
pii: 10.1038/s43856-023-00287-9
pmc: PMC10110614
doi:

Types de publication

Journal Article

Langues

eng

Pagination

54

Subventions

Organisme : NEI NIH HHS
ID : P30 EY001792
Pays : United States
Organisme : NEI NIH HHS
ID : R01 EY023522
Pays : United States
Organisme : NEI NIH HHS
ID : R01 EY030101
Pays : United States

Informations de copyright

© 2023. The Author(s).

Références

Am J Ophthalmol. 2019 Nov;207:363-372
pubmed: 31226248
Retina. 2022 Aug 1;42(8):1442-1449
pubmed: 35316256
Comput Med Imaging Graph. 2013 Oct-Dec;37(7-8):607-17
pubmed: 23849699
Biomed Opt Express. 2020 Aug 25;11(9):5249-5257
pubmed: 33014612
Exp Biol Med (Maywood). 2020 Feb;245(4):301-312
pubmed: 31958986
Med Image Anal. 2021 Jul;71:102035
pubmed: 33813286
Biomed Opt Express. 2019 Mar 26;10(4):2055-2066
pubmed: 31061771
Comput Biol Med. 2017 Nov 1;90:23-32
pubmed: 28917120
Transl Vis Sci Technol. 2020 Jul 02;9(2):35
pubmed: 32855839
Biomed Opt Express. 2023 Jan 26;14(2):906-917
pubmed: 36874492
Transl Vis Sci Technol. 2021 Aug 2;10(9):5
pubmed: 34342607
Invest Ophthalmol Vis Sci. 2018 Oct 1;59(12):4953-4962
pubmed: 30326063
PLoS One. 2018 Jun 28;13(6):e0199793
pubmed: 29953490
PLoS One. 2014 Feb 12;9(2):e88061
pubmed: 24533066
Ophthalmol Sci. 2022 Apr 01;2(2):100149
pubmed: 36278031
Biomed Opt Express. 2022 Feb 01;13(2):1121-1130
pubmed: 35284164
Am J Ophthalmol. 2020 Oct;218:214-224
pubmed: 32360344
IEEE Trans Image Process. 2014 Mar;23(3):1073-83
pubmed: 23693131
Light Sci Appl. 2022 Mar 18;11(1):63
pubmed: 35304441
Biomed Opt Express. 2020 Dec 15;12(1):367-379
pubmed: 33520388
Invest Ophthalmol Vis Sci. 2022 Feb 1;63(2):19
pubmed: 35142788
J Biomed Opt. 2016 Jun 1;21(6):66008
pubmed: 27286188
Front Med (Lausanne). 2022 Apr 08;9:864879
pubmed: 35463032
Exp Biol Med (Maywood). 2019 Jul;244(10):813-818
pubmed: 31088115
Invest Ophthalmol Vis Sci. 2016 Jul 1;57(9):OCT362-70
pubmed: 27409494
J Med Signals Sens. 2017 Apr-Jun;7(2):59-70
pubmed: 28553578
Quant Imaging Med Surg. 2021 Mar;11(3):1102-1119
pubmed: 33654680
Annu Int Conf IEEE Eng Med Biol Soc. 2016 Aug;2016:1320-1323
pubmed: 28268568
PLoS One. 2017 Nov 2;12(11):e0187336
pubmed: 29095872
Biomed Opt Express. 2022 Aug 22;13(9):4870-4888
pubmed: 36187235

Auteurs

Mansour Abtahi (M)

Department of Biomedical Engineering, University of Illinois at Chicago, Chicago, IL, 60607, USA.

David Le (D)

Department of Biomedical Engineering, University of Illinois at Chicago, Chicago, IL, 60607, USA.

Behrouz Ebrahimi (B)

Department of Biomedical Engineering, University of Illinois at Chicago, Chicago, IL, 60607, USA.

Albert K Dadzie (AK)

Department of Biomedical Engineering, University of Illinois at Chicago, Chicago, IL, 60607, USA.

Jennifer I Lim (JI)

Department of Ophthalmology and Visual Sciences, University of Illinois at Chicago, Chicago, IL, 60612, USA.

Xincheng Yao (X)

Department of Biomedical Engineering, University of Illinois at Chicago, Chicago, IL, 60607, USA. xcy@uic.edu.
Department of Ophthalmology and Visual Sciences, University of Illinois at Chicago, Chicago, IL, 60612, USA. xcy@uic.edu.

Classifications MeSH